After Canopy Growth (NYSE: CGC) reported its first quarter 2021 results yesterday, the shares jumped about 10% in the pre-market trading and
Canopy Growth’s (CGC) net loss narrows in Q1 on revenue growth and cost cuts; stock surges
Categories
Cannabis
Tilray Q2 loss widens despite revenue growth; results miss
https://www.youtube.com/watch?v=KqNZ-_X4F8k&t=2s Cannabis company Tilray, Inc. (NASDAQ: TLRY) Monday reported a wider net loss for the second quarter of 2020, despite a marked
Canopy Growth (CGC) Q1 2021 earnings in a nutshell
Canopy Growth (NYSE: CGC) reported an improvement in net loss for its first quarter ended 2021 with a revenue increase of 22%.
Cronos (CRON) Q2 Earnings: Key financials and quarterly highlights
Cronos Group Inc. (NASDAQ: CRON) reported second quarter 2020 earnings results today. Consolidated net revenues grew 29% year-over-year to $9.9 million, driven
Aphria (APHA) swings to a loss in Q4 despite 18% growth in revenue
Aphria (NASDAQ: APHA) stock plunged more than 10% in the pre-market trading session as it reported a loss of C$98 million or
4Front Ventures Corp (Other OTC: FFNTF) Q4 2019 Earnings Call Transcript
4Front Ventures Corp (FFNTF) Q4 2019 earnings call dated Jun. 15, 2020 Corporate Participants: Andrew Thut -- Chief Investment Officer Leo Gontmakher -- Chief Executive Officer
Neptune Wellness (NEPT) defies COVID crisis and looks to start FY21 on a high note
In several markets, the cannabis industry was less affected by the coronavirus than most other businesses, even as the authorities in some
HEXO Corp. (NYSE: HEXO) Q3 2020 Earnings Call Transcript
HEXO Corp. (HEXO) Q3 2020 earnings call dated June 11, 2020 Corporate Participants: Jennifer Smith -- Director of Investor Relations Sebastien St-Louis -- Co-founder and Chief
Infographic: Key highlights of HEXO Corp (HEXO) Q3 2020 earnings
HEXO Corp. (TSX: HEXO; NYSE: HEXO) reported a wider loss in the third quarter of 2020 due to higher expenses. The top-line
With right product mix and CAPEX discipline, Canopy Growth (CGC) can hit growth path
The latest quarterly performance of Canopy Growth Corporation (NYSE: CGC) was nothing short of a disaster, with the cannabis firm incurring a
Infographic: Highlights of Canopy Growth (CGC) Q4 2020 earnings results
Canopy Growth Corporation (NYSE: CGC) reported its financial results for the quarter ended March 31, 2020, on Friday before the market opens.
Village Farms (VFF): Regulatory uncertainty – a major roadblock for US CBD opportunity
Village Farms International Inc. (NASDAQ: VFF) reported total sales of $39.6 million for the first quarter of 2020 compared to $38.6 million
Infographic: Highlights of Aurora Cannabis (ACB) Q3 2020 Earnings Report
Aurora Cannabis, Inc. (NYSE: ACB) reported a narrower loss for the third quarter of 2020, aided by a 16% growth in revenues.
Arcadia Biosciences (RKDA): GoodHemp forms key part of growth strategy
Arcadia Biosciences (NASDAQ: RKDA) saw its revenues nearly double to $309,000 in the first quarter of 2020 versus the same period a
Tilray’s (TLRY) loss widens in Q1 despite minimal impact from COVID-19
Tilray (NASDAQ: TLRY) reported mixed results yesterday for its first quarter of 2020. Despite revenue rising more than 100% in the quarter,
GW Pharmaceuticals (GWPH): Investments in manufacturing and international expansion serve as strong growth drivers
GW Pharmaceuticals plc (NASDAQ: GWPH) has seen its stock gain over 17% in the past one month. The company delivered topline growth
Tilray Inc (NASDAQ: TLRY) Q1 2020 Earnings Call Transcript
Tilray Inc (TLRY) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Raphael Gross -- Investor Relations Brendan Kennedy -- Chief Executive Officer Michael Kruteck -- Chief
GW Pharmaceuticals PLC (NASDAQ: GWPH) Q1 2020 Earnings Call Transcript
GW Pharmaceuticals PLC (GWPH) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Stephen Schultz -- Vice President, Investor Relations Justin Gover -- Chief Executive
New products, global expansion might help Cronos Group beat Covid crisis
The cannabis market, which has been witnessing issues like low demand and the vaping crisis, is probably headed for a slowdown this
Cronos Group Inc. (NASDAQ: CRON) Q1 2020 Earnings Call Transcript
Cronos Group Inc. (CRON) Q1 2020 earnings call dated May 08, 2020 Corporate Participants: Shayne Laidlaw -- Investor Relations Mike Gorenstein -- Chairman, President and Chief
Cronos Group (CRON) Q1 profit dips 76% amid continued growth of cannabis
Cronos Group Inc. (NASDAQ: CRON) reported a 76% dip in earnings for the first quarter of 2020 due to higher operating expenses